EGFR overexpression and radiation response in glioblastoma multiforme (Q46868616)

26 December 2017

title

EGFR overexpression and radiation response in glioblastoma multiforme (English)

1 reference

26 December 2017

1 reference

1 reference

Barker FG 2nd

1

1 reference

26 December 2017

Simmons ML

2

1 reference

26 December 2017

Chang SM

3

1 reference

26 December 2017

Prados MD

4

1 reference

26 December 2017

Larson DA

5

1 reference

26 December 2017

Sneed PK

6

1 reference

26 December 2017

Wara WM

7

1 reference

26 December 2017

Berger MS

8

1 reference

26 December 2017

Chen P

9

1 reference

26 December 2017

Israel MA

10

1 reference

26 December 2017

Aldape KD

11

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 December 2017

International Journal of Radiation Oncology Biology Physics

published in

1 reference

26 December 2017

volume

51

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

410-418

1 reference

26 December 2017

Radiation response and survival time in patients with glioblastoma multiforme

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

EGF receptor amplification and expression in human brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Constitutional p53 mutations associated with brain tumors in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Collapsing ordered outcome categories: a note of concern.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Investigating development of infective stage larvae of filarial nematodes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Gene amplification in human gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Clinical evidence of distinct subgroups of astrocytic tumors defined by comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

The challenge of p53 as prognostic and predictive factor in gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Comparative study of p53 gene and protein alterations in human astrocytic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Molecular genetics of radiographically defined de novo glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Correlation of epidermal growth factor receptor and radiosensitivity in human maxillary carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells.Miko

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901609-1

7 January 2021

10.1016/S0360-3016(01)01609-1

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

11567815

1 reference

26 December 2017